Enzyme therapy for the lysosomal storage disorders: principles, patents, practice and prospects

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.8, 2003-08, pp. : 1157-1172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Lysosomal Storage Disorders: Progress with Enzyme Replacement Therapy

By Rohrbach Marianne Clarke Joe T.R.

Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. : 2697-2716

Adis International

Access to resources Recommend Favorite

Immunomodulatory Gene Therapy in Lysosomal Storage Disorders

Current Gene Therapy, Vol. 9, Iss. 6, 2009-12 ,pp. : 503-510

Bentham Science Publishers

Access to resources Recommend Favorite

A Chaperone-Mediated Approach to Enzyme Enhancement as a Therapeutic Option for the Lysosomal Storage Disorders

By Pastores Gregory M. Sathe Swati

Drugs in R&D, Vol. 7, Iss. 6, 2006-01 ,pp. : 339-348

Adis International

Access to resources Recommend Favorite

A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity

By Fan J.-Q.

Trends in Pharmacological Sciences, Vol. 24, Iss. 7, 2003-07 ,pp. : 355-360

Elsevier

Access to resources Recommend Favorite

Gene Therapy for Lysosomal Storage Diseases: Progress, Challenges and Future Prospects

Current Pharmaceutical Design, Vol. 17, Iss. 24, 2011-08 ,pp. : 2558-2574

Bentham Science Publishers

Access to resources Recommend Favorite